Exosome Diagnostics Garners $60,000,000 Series B Financing Round

  • Feed Type
  • Date
    1/7/2016
  • Company Name
    Exosome Diagnostics
  • Mailing Address
    840 Memorial Drive Cambridge, MA 02139 USA
  • Company Description
    Exosome Diagnostics, Inc. is focused on commercializing minimally invasive molecular diagnostics using body fluids.
  • Website
    http://www.exosomedx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $60,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Exosome Diagnostics expects to use the funds to support the growth of its commercial diagnostics, regulatory, and companion diagnostics divisions, as well as the development of potential new diagnostic tests outside of oncology, such as in neurodegenerative diseases, and expand the development of its protein biomarker programs. These divisions and technology differentiators, such as its protein biomarker interrogation capabilities, will further distinguish Exosome Diagnostics as the industry leader in the liquid biopsy space.
  • M&A Terms
  • Venture Investor
    Forbion Capital Partners
  • Venture Investor
    NGN Capital
  • Venture Investor
    CD Ventures
  • Venture Investor
    Qiagen
  • Venture Investor
    Arcus Ventures
  • Venture Investor
    Tiger Global Management

Trending on Xconomy